NPRTX | VIVIX | NPRTX / VIVIX | |
Total Expense Ratio | 0.76 | 0.04 | 1,900% |
Annual Report Gross Expense Ratio | 0.76 | 0.04 | 1,900% |
Fund Existence | 51 years | 27 years | - |
Gain YTD | 11.119 | 7.866 | 141% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.31B | 203B | 4% |
Annual Yield % from dividends | 1.96 | 2.11 | 93% |
Returns for 1 year | 9.05 | 7.74 | 117% |
Returns for 3 years | 30.68 | 36.61 | 84% |
Returns for 5 years | 78.28 | 70.16 | 112% |
Returns for 10 years | 107.23 | 131.61 | 81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 70.01 | 0.54 | +0.78% |
Janus Henderson Global Life Sciences T | |||
RFNBX | 90.23 | 0.50 | +0.56% |
American Funds Fundamental Invs R2 | |||
LICYX | 17.90 | 0.09 | +0.51% |
Lord Abbett International Equity I | |||
MGBRX | 17.76 | 0.03 | +0.17% |
MFS Global Total Return R2 | |||
ETMGX | 31.78 | 0.05 | +0.16% |
Eaton Vance Tx-Mgd Small-Cap A |